Riskpilot← Back to searchSign inGet full accessSALTEN SYNSSENTER AS
ASActiveOrg 984300387Terminalveien 5, 8208 FauskeRetail sale of medical and orthopaedic goods · NACE 4774Est. 20019 employeeswww.saltensynssenter.no
Revenue 2024
NOK 7,2M
+1% vs 2023
EBITDA margin
3.0%
+364% vs 2023
Equity ratio
38.7%
Financial strength
Net profit 2024
NOK 41K
+134% vs 2023
| Revenue | NOK 7,2M | +1% |
| EBITDA | NOK 216K | +364% |
| Net profit | NOK 41K | +134% |
| Total assets | NOK 3,2M | +17% |
| Equity | NOK 1,3M | +3% |
| Employees | 9 | — |
Legal name
SALTEN SYNSSENTER AS
Org number
984300387
Legal form
Aksjeselskap
NACE code
4774 · Retail sale of medical and orthopaedic goods
Founded
31. desember 2001
Share capital
NOK 1 000 000
Employees
9 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder og ett styremedlem i fellesskap.
Company purpose
Salg av optiske varer og tjenester.
Address
Terminalveien 5, 8208 Fauske
Website
www.saltensynssenter.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 6 961 | 6 822 | 5 399 | 7 093 | 7 195 |
| Staff expenses | −2 852 | −3 435 | −2 637 | −2 417 | −2 488 |
| EBITDA | 787 | 400 | −55 | 47 | 216 |
| Depreciation & amort. | −196 | −165 | −139 | −161 | −180 |
| EBIT | 591 | 235 | −194 | −114 | 36 |
| Net financials | −69 | −71 | −42 | −7 | 6 |
| Profit before tax | 521 | 164 | −236 | −121 | 41 |
| Tax | 114 | 33 | −9 | −0 | −0 |
| Net profit | 407 | 131 | −227 | −121 | 41 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 3 413 | 3 121 | 2 542 | 2 754 | 3 231 |
| Equity | 1 425 | 1 557 | 1 330 | 1 209 | 1 250 |
| Long-term debt | 1 173 | 763 | 541 | 484 | 426 |
| Short-term debt | 815 | 801 | 671 | 1 061 | 1 555 |
| Total debt | 1 987 | 1 564 | 1 212 | 1 545 | 1 981 |
EBITDA margin
3.0%
This company
15.8%
Market median
-81% vs market
20202024
Equity ratio
38.7%
This company
38.2%
Market median
+1% vs market
20202024
Return on equity
3.3%
This company
18.4%
Market median
-82% vs market
20202024
Net profit margin
0.6%
This company
8.1%
Market median
-93% vs market
20202024
Asset turnover
2.23×
This company
1.12×
Market median
+99% vs market
20202024
Debt / equity
1.58×
This company
0.62×
Market median
-155% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Former (2) | ||
AK Deputy Member | Deputy Member | 2011 – 2022 |
AL Chief Executive Officer | Chief Executive Officer | 2002 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Chairman | 2022 | |
| Former (1) | ||
| Chairman | 2011 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Nk Holding As
SALTEN SYNSSENTER AS Board members of SALTEN SYNSSENTER AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ann-Karin Kristensen | Deputy Member | 0 companies |
| Asbjørn Lorentzen | Chief Executive Officer | 0 companies |
| Fredrik Sandum Kristiansen | Board of Directors | 0 companies |
| Benedikte Nikolaisen | Chairman | 0 companies |
| Siw Lisbeth Ingebrigtsen Stien | Chairman | 0 companies |